PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Clinical trials for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One pill vs. three: new hope for easier PAH treatment
Disease control CompletedThis study tested if a single pill combining two existing PAH medications (macitentan and tadalafil) works better and is easier for patients than taking the two medications separately. It involved 187 adults with PAH who were randomly assigned to take either the combination pill …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Simple breathing technique tested to ease debilitating lung disease symptoms
Symptom relief CompletedThis study tested whether a slow-paced breathing exercise, practiced at home using a guided video, could help adults with pulmonary arterial hypertension. Researchers wanted to see if this simple technique could improve symptoms like shortness of breath and fatigue, increase walk…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Simple scan could sharpen deadly lung disease risk predictions
Knowledge-focused CompletedThis study tested whether a new ultrasound scoring method, called VExUS, could help doctors better assess risk in patients with pulmonary arterial hypertension (PAH). Researchers compared the ultrasound score to the standard risk assessment tools and measurements taken during a h…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC